Alcon launches first medicine to treat vitreomacular traction in UK
Jetrea administered through a single intravitreal injection to treat VMT even when coupled with macular hole of diameter less than or equal to 400 microns. ThromboGenics CEO Dr
The US Food and Drug Administration (FDA) has granted accelerated approval to Bristol Myers Squibb’s (BMS) Zenbexus (iberdomide), along with daratumumab and hyaluronidase-fihj and dexamethasone (ZDd), to treat adult multiple myeloma (MM) patients.
Headquartered in Helsinki, Finland, the new company Mobidiag integrates Mobidiag’s and Amplidiag’s high-multiplex proprietary diagnostic test portfolios with Genewave’s automated and integrated test platform. Mobidiag CEO Tuomas Tenkanen
The combination of Proteros’ structure guided discovery with Priaxon’s PPI-directed drug discovery platforms will be focused on the identification of novel small molecule modulators for PPI targets, according